NAPAJEN PHARMA INC has a total of 28 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2011. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are HAN HOON, CYTOVAC AS and DIABCELL PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | United States | 3 | |
#4 | China | 2 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | Israel | 1 | |
#9 | Japan | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Sugars | |
#6 | Polysaccharides |
# | Name | Total Patents |
---|---|---|
#1 | Higuchi Sadaharu | 23 |
#2 | Ando Hironori | 22 |
#3 | Sakurai Kazuo | 11 |
#4 | Uno Atsushi | 11 |
#5 | Kobayashi Masakazu | 5 |
#6 | Rii Ko | 4 |
#7 | Takahara Shiro | 4 |
#8 | Mochizuki Shinichi | 3 |
#9 | Amano Kanako | 3 |
#10 | Ushida Maki | 3 |
Publication | Filing date | Title |
---|---|---|
EP3804763A1 | Pharmaceutical composition containing complex of chemically-modified sirna and schizophyllan | |
US2020038428A1 | Cancer cell adhesion activity inhibitor | |
US2019382762A1 | CHEMICALLY-MODIFIED siRNA | |
EP3473641A1 | Nucleic acid-antigen peptide conjugate | |
EP2742944A1 | Immune tolerance inducer | |
EP2682462A1 | (nucleic acid)-polysaccharide complex | |
WO2012020795A1 | Nucleic acid/polysaccharide complex | |
WO2012008465A1 | (nucleic acid)-polysaccharide complex |